CD4 and interstitial lung disease: Among the identified endotypes, Endotype1 exhibited the best prognosis with the lowest incidence of death in 3 months, inpatient death, and inpatient ILD progression; it had the highest percentage of CD4+ T cells and monocytes, and the lowest percentage of neutrophils.